JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A8250 LY 294002
16 Citation

Target: PI3K

Summary: Potent PI3K inhibitor
A2067 PI-103
1 Citation

Summary: Class I PI3K, mTOR and DNA-PK inhibitor

≥21.9 mg/mL
A2846 OSU-03012 (AR-12)
1 Citation

Target: PDK-1

Summary: Potent PDK1 inhibitor

≥23 mg/mL
A5112 XL147

Target: PI3K

Summary: PI3K inhibitor,selective and reversible

≥22.45 mg/mL
A2681 TGX-221

Target: PI3K

Summary: PI3Kβ inhibitor,potent,selective and ATP competitive

insoluble in H2O; insoluble in EtOH; ≥68.7 mg/mL
A5078 KU-0063794

Target: mTOR

Summary: MTORC1 and mTORC2 inhibitor

insoluble in H2O; insoluble in EtOH; ≥11.65 mg/mL
A2552 Quercetin dihydrate

Target: PI3K|PIM1 kinase|phospholipase A2

Summary: PLA2 and PI 3-kinase inhibitor

≥33.8 mg/mL
A5072 GSK690693

Target: Akt|PKC|PKG|PKA|Prk

Summary: Pan-AKT inhibitor,ATP-competitive and potent

≥21.25 mg/mL
A1266 WYE-354

Summary: MTOR inhibitor,potent,ATP-competitive and cell-permeable

≥49.6 mg/mL
A2754 TG100-115

Target: PI3K

Summary: PI3Kγ/PI3Kδ inhibitor

insoluble in H2O; insoluble in EtOH; ≥3.46 mg/mL